Technical Analysis for AVCT - Avacta Group Plc

Grade Last Price % Change Price Change
A 161.10 1.64% 2.60
AVCT closed up 1.64 percent on Friday, February 3, 2023, on 81 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
NR7 Range Contraction 1.64%
Multiple of Ten Bearish Other 1.64%
Wide Bands Range Expansion 1.64%
180 Bullish Setup Bullish Swing Setup 4.61%
Multiple of Ten Bullish Other 4.61%
Wide Bands Range Expansion 4.61%
Gapped Up Strength 4.61%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
3x Volume Pace 2 days ago
2x Volume Pace 2 days ago
1.5x Volume Pace 2 days ago
Rose Above Previous Day's High 2 days ago
Up 3% 2 days ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Avacta Group Plc Description

Avacta Group plc is a biotechnology company. Avacta's focus is on its proprietary Affimer technology which is an engineered alternative to antibodies that has application in Life Sciences for diagnostics, therapeutics and general research and development. Affimer technology has been designed to address performance limitations of antibodies. Affimer technology is based on a small protein that can be generated to bind with specificity and affinity to a range of targets to enable diagnostics, research assays and therapeutics. Avacta has a pre-clinical therapeutic development programme with an in-house focus on immuno-oncology and bleeding disorders as well as partnered development programmes. Avacta is commercialising non-therapeutic Affimer reagents through licensing to developers of life sciences research tools and diagnostics.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Biotechnology Science Medicine Tools Life Sciences Clinic Branches Of Biology Medical Specialties Oncology Immunology Immune System Antibodies Assay Disorders Aptamer Synthetic Antibody

Is AVCT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 168.0
52 Week Low 38.0
Average Volume 2,020,644
200-Day Moving Average 116.41
50-Day Moving Average 125.65
20-Day Moving Average 147.13
10-Day Moving Average 153.35
Average True Range 9.32
RSI 63.90
ADX 33.64
+DI 30.00
-DI 13.17
Chandelier Exit (Long, 3 ATRs) 140.04
Chandelier Exit (Short, 3 ATRs) 148.96
Upper Bollinger Bands 171.84
Lower Bollinger Band 122.41
Percent B (%b) 0.78
BandWidth 33.59
MACD Line 8.88
MACD Signal Line 9.15
MACD Histogram -0.2699
Fundamentals Value
Market Cap 407.02 Million
Num Shares 253 Million
EPS -11.60
Price-to-Earnings (P/E) Ratio -13.89
Price-to-Sales 31.35
Price-to-Book 4.14
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 173.78
Resistance 3 (R3) 174.00 170.00 171.66
Resistance 2 (R2) 170.00 166.77 169.89 170.96
Resistance 1 (R1) 165.55 164.78 167.78 165.33 170.25
Pivot Point 161.55 161.55 162.66 161.44 161.55
Support 1 (S1) 157.10 158.32 159.33 156.88 151.95
Support 2 (S2) 153.10 156.33 152.99 151.24
Support 3 (S3) 148.65 153.10 150.54
Support 4 (S4) 148.43